Autolus Therapeutics PLC (AUTL) is down Friday morning, with the stock declining -29.43% in pre-market trading to 2.11. AUTL's short-term technical score of 12 indicates that the stock has traded less bullishly over the last month than 88% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, AUTL ranks higher than 18% of stocks. Autolus Therapeutics PLC has risen 45.15% over the past month, closing at $2.22 on November 11. During this period of time, the stock fell as low as $2.00 and as high as $3.53. AUTL has an average analyst recommendation of Strong Buy. The company has an average price target of $10.40.
Autolus Therapeutics PLC has a Long-Term Technical rank of 50. This means that trading over the last 200 trading days has placed the company in the middle with 50% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, AUTL ranks better than 130% of stocks.
Autolus Therapeutics PLC (AUTL) is down 29.43% Friday In Premarket Trading
AUTL has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on AUTL!